Join us for an Expert Discussion on LYNPARZA - February 15th, 2023Social Media CoordinatorFeb 4, 20231 min readRSVP Required by February 10th! Contact Katie Naylor at KAtie.naylor@astrazeneca.com or 203-980-2353Justin Julius 2 15 2023.pdfDownload PDF • 339KB
CAR-Therapy Adverse Reaction Identification and Management Considerations ~ Thursday, June 12th @ Davio's
NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1
NEW EVENT! Make a Change in cGVHD Treatment Strategy and Provide Rapid, Durable Responses ~ March 19th, 2025 at Joe's on Newbury
Comments